The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Incidence of Stress Cardiomyopathy During the Coronavirus Disease 2019 Pandemic
Open accessAbstract
Importance: The coronavirus disease 2019 (COVID-19) pandemic has resulted in severe psychological, social, and economic stress in people's lives. It is not known whether the stress of the pandemic is associated with an increase in the incidence of stress cardiomyopathy. Objective: To determine the incidence and outcomes of stress cardiomyopathy during the COVID-19 pandemic compared with before the pandemic. Design, Setting, and Participants: This retrospective cohort study at cardiac catheterization laboratories with primary percutaneous coronary intervention capability at 2 hospitals in the Cleveland Clinic health system in Northeast Ohio examined the incidence of stress cardiomyopathy (also known as Takotsubo syndrome) in patients presenting with acute coronary syndrome who underwent coronary arteriography. Patients presenting during the COVID-19 pandemic, between March 1 and April 30, 2020, were compared with 4 control groups of patients with acute coronary syndrome presenting prior to the pandemic across 4 distinct timelines: March to April 2018, January to February 2019, March to April 2019, and January to February 2020. Data were analyzed in May 2020. Exposures: Patients were divided into 5 groups based on the date of their clinical presentation in relation to the COVID-19 pandemic. Main Outcomes and Measures: Incidence of stress cardiomyopathy. Results: Among 1914 patient presenting with acute coronary syndrome, 1656 patients (median [interquartile range] age, 67 [59-74]; 1094 [66.1%] men) presented during the pre-COVID-19 period (390 patients in March-April 2018, 309 patients in January-February 2019, 679 patients in March-April 2019, and 278 patients in January-February 2020), and 258 patients (median [interquartile range] age, 67 [57-75]; 175 [67.8%] men) presented during the COVID-19 pandemic period (ie, March-April 2020). There was a significant increase in the incidence of stress cardiomyopathy during the COVID-19 period, with a total of 20 patients with stress cardiomyopathy (incidence proportion, 7.8%), compared with prepandemic timelines, which ranged from 5 to 12 patients with stress cardiomyopathy (incidence proportion range, 1.5%-1.8%). The rate ratio comparing the COVID-19 pandemic period to the combined prepandemic period was 4.58 (95% CI, 4.11-5.11; P < .001). All patients during the COVID-19 pandemic had negative reverse transcription-polymerase chain reaction test results for COVID-19. Patients with stress cardiomyopathy during the COVID-19 pandemic had a longer median (interquartile range) hospital length of stay compared with those hospitalized in the prepandemic period (COVID-19 period: 8 [6-9] days; March-April 2018: 4 [3-4] days; January-February 2019: 5 [3-6] days; March-April 2019: 4 [4-8] days; January-February: 5 [4-5] days; P = .006). There were no significant differences between the COVID-19 period and the overall pre-COVID-19 period in mortality (1 patient [5.0%] vs 1 patient [3.6%], respectively; P = .81) or 30-day rehospitalization (4 patients [22.2%] vs 6 patients [21.4%], respectively; P = .90). Conclusions and Relevance: This study found that there was a significant increase in the incidence of stress cardiomyopathy during the COVID-19 pandemic when compared with prepandemic periods.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prasad, A., Lerman, A., & Rihal, C. S. (2008) · American Heart Journal · doi:10.1016/j.ahj.2007.11.008 · Cited by 1,840
Ghadri, J.-R., Wittstein, I. S., Prasad, A., Sharkey, S., Dote, K., Akashi, Y. J., Cammann, V. L., Crea, F., Galiuto, L., Desmet, W., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy076 · Cited by 1,600
Coronavirus Disease 2019 (COVID-19): Role of Chest CT in Diagnosis and Management
Li, Y., & Xia, L. (2020) · American Journal of Roentgenology · doi:10.2214/ajr.20.22954 · Cited by 1,294
Takotsubo Cardiomyopathy: A New Form of Acute, Reversible Heart Failure
Akashi, Y. J., Goldstein, D. S., Barbaro, G., & Ueyama, T. (2008) · Circulation · doi:10.1161/circulationaha.108.767012 · Cited by 808
Sala, S., Peretto, G., Gramegna, M., Palmisano, A., Villatore, A., Vignale, D., De Cobelli, F., Tresoldi, M., Cappelletti, A. M., Basso, C., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa286 · Cited by 481
Mehta, N., Kalra, A., Nowacki, A. S., Anjewierden, S., Han, Z., Bhat, P., Carmona-Rubio, A. E., Jacob, M., Procop, G. W., Harrington, S., et al. (2020) · JAMA Cardiology · doi:10.1001/jamacardio.2020.1855 · Cited by 400
Self-citationIMPACT OF HUMAN DISASTERS AND COVID-19 PANDEMIC ON MENTAL HEALTH: POTENTIAL OF DIGITAL PSYCHIATRY
Laboratory for Interactive Simulation Systems, F. O. E. E. A. C., Cosic, K., Popovic, S., Laboratory for Interactive Simulation Systems, F. O. E. E. A. C., Sarlija, M., Laboratory for Interactive Simulation Systems, F. O. E. E. A. C., Kesedzic, I., & Laboratory for Interactive Simulation Systems, F. O. E. E. A. C. (2020) · Psychiatria Danubina · doi:10.24869/psyd.2020.25 · Cited by 294
Cardiac Tamponade Secondary to COVID-19
Dabbagh, M. F., Aurora, L., D’Souza, P., Weinmann, A. J., Bhargava, P., & Basir, M. B. (2020) · JACC: Case Reports · doi:10.1016/j.jaccas.2020.04.009 · Cited by 180
(2018) · Psychiatria Danubina · doi:10.24869/psyd · Cited by 11
Cited by
Nalbandian, A., Sehgal, K., Gupta, A., Madhavan, M. V., McGroder, C., Stevens, J. S., Cook, J. R., Nordvig, A. S., Shalev, D., Sehrawat, T. S., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01283-z · Cited by 4,862
Inflammatory Cytokines and Chemokines as Therapeutic Targets in Heart Failure
Hanna, A., & Frangogiannis, N. G. (2020) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-020-07071-0 · Cited by 418
Takotsubo Syndrome: Pathophysiology, Emerging Concepts, and Clinical Implications
Singh, T., Khan, H., Gamble, D. T., Scally, C., Newby, D. E., & Dawson, D. (2022) · Circulation · doi:10.1161/circulationaha.121.055854 · Cited by 396
Metadata
- Authors
- Jabri, A., Kalra, A., Kumar, A., Alameh, A., Adroja, S., Bashir, H., Nowacki, A. S., Shah, R., Khubber, S., Kanaa’N, A., Hedrick, D. P., Sleik, K. M., Mehta, N., Chung, M. K., Khot, U. N., Kapadia, S. R., Puri, R., & Reed, G. W.
- Venue
- JAMA Network Open
- Publisher
- American Medical Association (AMA)
- Published
- 2020-07-09
- Volume
- 3
- Issue
- 7
- Pages
- e2014780
- ISSN
- 2574-3805 (ISSN-L)
- OpenAlex
- W3041814516
- Cited by
- 271
- References
- 9
- FWCI
- 31.00
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Incidence of Stress Cardiomyopathy During the Coronavirus Disease 2019 Pandemic. https://app.cochat.ai/papers/10.1001/jamanetworkopen.2020.14780
- The paper
- Jabri, A., Kalra, A., Kumar, A., Alameh, A., Adroja, S., Bashir, H., Nowacki, A. S., Shah, R., Khubber, S., Kanaa’N, A., Hedrick, D. P., Sleik, K. M., Mehta, N., Chung, M. K., Khot, U. N., Kapadia, S. R., Puri, R., & Reed, G. W. (2020). Incidence of Stress Cardiomyopathy During the Coronavirus Disease 2019 Pandemic. JAMA Network Open. https://doi.org/10.1001/jamanetworkopen.2020.14780
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.